328 related articles for article (PubMed ID: 28694201)
1. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
[TBL] [Abstract][Full Text] [Related]
2. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
[TBL] [Abstract][Full Text] [Related]
3. Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB Gold In-Tube assay of routine laboratory practice.
Woo KS; Choi JL; Kim BR; Kim JE; Kim BG; Lee H; Kim KH
Clin Chim Acta; 2014 Mar; 430():79-83. PubMed ID: 24389051
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response.
Sauzullo I; Mengoni F; Ermocida A; Massetti AP; D'Agostino C; Russo G; Salotti A; Falciano M; Vullo V; Mastroianni CM
New Microbiol; 2014 Apr; 37(2):153-61. PubMed ID: 24858642
[TBL] [Abstract][Full Text] [Related]
5. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract][Full Text] [Related]
6. Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.
Siegel SAR; Cavanaugh M; Ku JH; Kawamura LM; Winthrop KL
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232132
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
[TBL] [Abstract][Full Text] [Related]
8. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
9. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
10. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
13. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.
Chi CY; Chu CC; Liu JP; Lin CH; Ho MW; Lo WJ; Lin PC; Chen HJ; Chou CH; Feng JY; Fung CP; Sher YP; Li CY; Wang JH; Ku CL
Blood; 2013 Feb; 121(8):1357-66. PubMed ID: 23243276
[TBL] [Abstract][Full Text] [Related]
14. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
[TBL] [Abstract][Full Text] [Related]
16. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
[TBL] [Abstract][Full Text] [Related]
17. Fluctuating Behavior and Influential Factors in the Performance of the QuantiFERON-TB Gold In-Tube Assay in the Diagnosis of Tuberculosis.
Bao L; Li T; Diao N; Shen Y; Shao L; Zhang Y; Lu S; Zhang W
PLoS One; 2015; 10(8):e0103763. PubMed ID: 26287382
[TBL] [Abstract][Full Text] [Related]
18. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
19. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
[TBL] [Abstract][Full Text] [Related]
20. Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.
Whitworth WC; Goodwin DJ; Racster L; West KB; Chuke SO; Daniels LJ; Campbell BH; Bohanon J; Jaffar AT; Drane W; Sjoberg PA; Mazurek GH
PLoS One; 2014; 9(1):e86721. PubMed ID: 24466211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
